American Express initiated with a Perform at Oppenheimer Oppenheimer started shares of American Express with a Perform rating citing valuation and headwinds facing the company's International Card Segment and Global Corporate Segment.
June 13, 2013 - Theflyonthewall.com via Yahoo! Finance
Incyte Jakafi outlook still positive after label revisions, says Oppenheimer After the FDA revised the label of Incyte's Jakafi drug by adding new recommended dosing for patients with low platelet counts and a warning about PML, Oppenheimer views the dosing change as positive and ...
June 13, 2013 - Theflyonthewall.com via Yahoo! Finance